Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Schütz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|January 22, 2015
Two-stage designs in bioequivalence trialsHelmut Schütz
European Journal of Drug Metabolism and Pharmacokinetics|May 21, 2004
An extremely strange observation?Helmut Schütz
Pharmaceutical Research|August 3, 2016
Inflation of Type I Error in the Evaluation of Scaled Average Bioequivalence, and a Method for its ControlDetlew Labes, Helmut Schütz
The AAPS Journal|September 13, 2014
Reference datasets for 2-treatment, 2-sequence, 2-period bioequivalence studiesHelmut Schütz, Detlew Labes, Anders Fuglsang
The AAPS Journal|December 10, 2014
Reference datasets for bioequivalence trials in a two-group parallel designAnders Fuglsang, Helmut Schütz, Detlew Labes
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 16, 2022
Critical Remarks on Reference-Scaled Average BioequivalenceHelmut Schütz, Detlew Labes, Martin J Wolfsegger
Analytical and Bioanalytical Chemistry|May 12, 2011
Quantitative determination of methylphenidate in plasma by gas chromatography negative ion chemical ionisation mass spectrometry using o-(pentafluorobenzyloxycarbonyl)-benzoyl derivativesHans J Leis, Helmut Schütz, Werner Windischhofer
Biometrical Journal. Biometrische Zeitschrift|October 1, 2020
An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designsEduard Molins, Detlew Labes, Helmut Schütz, et al.
Pharmaceutical Statistics|March 17, 2026
Paired and AB/BA Cross-Over Design in Early Phase Clinical Trials: A Closer Look at Within-Subject Variance BiasMartin J Wolfsegger, Peixin Xu, Amy Cotterill, et al.
Scandinavian Journal of Child and Adolescent Psychiatry and Psychology|November 30, 2023
Pharmacokinetics of a Modified-Release Dexamphetamine Sulfate Formulation Following Single and Multiple Dosing in Healthy Adults: Comparative Bioavailability with Immediate-Release Dexamphetamine Sulfate, between Strengths, Assessment of Food and Meal Composition EffectsHenrik Uebel-von Sandersleben, Anke Mayer, Michaela Ruhmann, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|January 22, 2015
Two-stage designs in bioequivalence trialsHelmut Schütz
European Journal of Drug Metabolism and Pharmacokinetics|May 21, 2004
An extremely strange observation?Helmut Schütz
Pharmaceutical Research|August 3, 2016
Inflation of Type I Error in the Evaluation of Scaled Average Bioequivalence, and a Method for its ControlDetlew Labes, Helmut Schütz
The AAPS Journal|September 13, 2014
Reference datasets for 2-treatment, 2-sequence, 2-period bioequivalence studiesHelmut Schütz, Detlew Labes, Anders Fuglsang
The AAPS Journal|December 10, 2014
Reference datasets for bioequivalence trials in a two-group parallel designAnders Fuglsang, Helmut Schütz, Detlew Labes
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 16, 2022
Critical Remarks on Reference-Scaled Average BioequivalenceHelmut Schütz, Detlew Labes, Martin J Wolfsegger
Analytical and Bioanalytical Chemistry|May 12, 2011
Quantitative determination of methylphenidate in plasma by gas chromatography negative ion chemical ionisation mass spectrometry using o-(pentafluorobenzyloxycarbonyl)-benzoyl derivativesHans J Leis, Helmut Schütz, Werner Windischhofer
Biometrical Journal. Biometrische Zeitschrift|October 1, 2020
An iterative method to protect the type I error rate in bioequivalence studies under two-stage adaptive 2×2 crossover designsEduard Molins, Detlew Labes, Helmut Schütz, et al.
Pharmaceutical Statistics|March 17, 2026
Paired and AB/BA Cross-Over Design in Early Phase Clinical Trials: A Closer Look at Within-Subject Variance BiasMartin J Wolfsegger, Peixin Xu, Amy Cotterill, et al.
Scandinavian Journal of Child and Adolescent Psychiatry and Psychology|November 30, 2023
Pharmacokinetics of a Modified-Release Dexamphetamine Sulfate Formulation Following Single and Multiple Dosing in Healthy Adults: Comparative Bioavailability with Immediate-Release Dexamphetamine Sulfate, between Strengths, Assessment of Food and Meal Composition EffectsHenrik Uebel-von Sandersleben, Anke Mayer, Michaela Ruhmann, et al.
Pageof 2